FindTrial
Sign In

Nuclear Fragment Protection Technology For Improving Efficiency and Safety in Phacoemulsification Surgery of Dense Nuclear Cataracts, A Randomized Controlled Clinical Trial

Nuclear Fragment Protection Technology For Improving Efficiency and safety in Phacoemulsification Surgery of Dense Nuclear Cataracts, A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112960
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Nuclear Fragment Protection Group:Phacoemulsification using Nuclear Protection Technology
Conventional Technique Group:Phacoemulsification using Conventional Technology

Sponsors

Hainan Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with grade 4 or grade 5 nuclear age-related cataracts

Exclusion criteria

Exclusion criteria: Patients with traumatic cataracts, complicated cataracts, or cataracts combined with corneal diseases, fundus pathologies, glaucoma, or a history of intraocular surgery

Design outcomes

Primary

MeasureTime frame
Ultrasound Time;Cumulative Dissipated Energy ;—

Countries

China

Contacts

Public ContactMingbing Zeng

Hainan Eye Hospital

zengmingb@mail.sysu.edu.cn+86 136 4021 8180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026